Stockreport

Quantum Biopharma Announces the Success of unbuzzd™ Clinical Trial

Quantum Biopharma Ltd. - Class B Subordinate Voting Shares  (QNTM) 
PDF TORONTO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a bio [Read more]